Fabiao Zhang

Dr. Fabiao Zhang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2023 in International Immunopharmacology
Verified
Journal Article
Open access
ZWZhonghan Wu
Zhonghan Wu
JZJingjing Zheng
Jingjing Zheng
HZHaoke Zhang
Haoke Zhang
NSNingzhe Shen
Ningzhe Shen
XLXiaohui Luo
Xiaohui Luo
SFShiyu Feng
Shiyu Feng
Gastric cancer (GC) is the most common form of gastrointestinal cancer, with a high mortality rate and limited treatment options. High levels of NEK2 are associated with malignant progression and a poor prognosis in several tumors; however, the role of NEK2 in GC remains unclear. We aimed to explore the potential role of NEK2 in the oncogenesis of GC and in the shaping of the tumor microenvironment (TME). The expression levels of NEK2 were analyzed using immunohistochemistry and real-time quantitative polymerase chain reaction. We found that NEK2 expression was upregulated in GC and was a predictor of a poor prognosis. Based on Kyoto Encyclopedia of Genes and Genomes pathway enrichment and gene set enrichment analyses, multiple tumor pathways were hyperactivated in patients with high NEK2 mRNA expression. Immunological characteristics indicated that NEK2 upregulation might lead to decreased immune cell infiltration and weakened immune activity in the cancer immunity cycle. Additionally, higher frequencies of amplifications and deletions were observed in the high NEK2 expression subpopulation. Based on the TME classification, patients with high expression of NEK2 were more susceptible to targeted therapy with drugs targeting the cell cycle and DNA replication. Following verification, a NEK2-derived genomic model reliably predicted the patient prognosis; A nomogram (radiation therapy, tumor/node/metastasis staging, and the NEK2-derived risk score) was used to better estimate an individual's survival probability. In summary, our findings indicate that NEK2 plays a vital role in the tumorigenesis of GC.

12 April 2024 in Cancer Medicine
Verified
Journal Article
Open access
QWQi Wang
Qi Wang
YHYuxi Huang
Yuxi Huang
YZYu Zhu
Yu Zhu
WZWenlong Zhang
Wenlong Zhang
BWBinfeng Wang
Binfeng Wang
ZFZheping Fang
Zheping Fang
Background: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide, it has a poor prognosis due to its highly invasive and metastatic nature. Consequently, identifying effective prognostic markers and potential therapeutic targets has been extensively investigated. METTL5, an 18S rRNA methyltransferase, is abnormally high in HCC. But its biological function and prognostic significance in HCC remain largely unelucidated. This study aimed to investigate the role of METTL5 in HCC progression, and elucidate its possible molecular mechanisms in HCC via transcriptome sequencing, providing new insights for identifying new HCC prognostic markers and therapeutic targets.Methods: The METTL5 expression in HCC and paracancerous tissues was analyzed using HCC immunohistochemical microarrays and bioinformatic retrieval methods to correlate METTL5 with clinicopathological features and survival prognosis. We constructed a METTL5 knockdown hepatocellular carcinoma cell line model and an animal model to determine the effect of METTL5 on hepatocellular carcinoma progression. Subsequently, RNA sequencing was performed to analyze the molecular mechanism of METTL5 in HCC based on the sequencing results, and relevant experiments were performed to verify it.Results: We found that METTL5 expression was elevated in hepatocellular carcinoma tissues and correlated with poor patient prognosis, and in the analysis of clinicopathological features showed a correlation with TNM staging. In hepatocellular carcinoma cell lines with knockdown of METTL5, the malignant biological behavior was significantly reduced both in vitro and in vivo. Based on the sequencing results as well as the results of GO functional enrichment analysis and KEGG pathway enrichment analysis, we found that METTL5 could promote the generation and release of neutrophil extracellular capture network (NETs) and might further accelerate the progression of HCC.Conclusion: The m6A methyltransferase METTL5 is overexpressed in hepatocellular carcinoma (HCC) and correlates with poor prognosis. METTL5 accelerates malignant progression of HCC by promoting generation and release of the neutrophil extracellular traps (NETs) network, providing new insights for clinical biomarkers and immunotherapeutic targets in HCC prognosis.

29 September 2025 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
LHLingbo Hu
Lingbo Hu
XSXingpeng Shi
Xingpeng Shi
AWAidong Wang
Aidong Wang
FZFabiao Zhang
Fabiao Zhang
Hepatectomy can be performed via laparoscopic liver resection (LLR), open liver resection (OLR), and robotic liver resection (RLR). However, the advantages of RLR over LLR and OLR with respect to the prognosis and perioperative outcomes of individuals with hepatocellular carcinoma (HCC) remain unclear. This study was designed to compare the perioperative and prognostic outcomes of RLR with those of LLR and OLR in patients with HCC. A comprehensive literature search was conducted in Embase, the Cochrane Library, PubMed, and Web of Science using the following keywords: “liver resection,” “robotic,” and “hepatocellular carcinoma.” The primary endpoints were overall survival (OS) and recurrence-free survival (RFS), with outcomes expressed as hazard ratios (HRs) and corresponding 95% confidence intervals (CIs). Secondary endpoints were perioperative outcomes, including resection margin status, intraoperative blood loss, transfusion requirement, operative time, conversion rate, postoperative complications, and length of hospital stay, reported as risk ratios (RRs) or mean differences (MDs) with 95% CIs. Eighteen studies involving 4,098 patients were included. Twelve studies reported the long-term prognosis of patients, with six comparing RLR with LLR, four comparing RLR with OLR, and two comparing RLR with LLR and OLR. Sixteen studies reported perioperative outcomes. The meta-analysis illustrated that RLR was associated with improved RFS (HR 0.78, 95% CI 0.64–0.94; p = 0.0092) and OS (HR 0.72, 95% CI 0.56–0.92; p = 0.0101) compared with LLR. No significant differences in OS and RFS were observed between RLR and OLR. Compared with LLR, RLR was associated with a lower conversion rate to laparotomy (RR 0.50, 95% CI 0.31–0.79; p = 0.0034) and a longer operative time (MD 30.69 min, 95% CI 9.56–51.82; p = 0.0044). RLR also resulted in significantly lower rates of overall complications (RR 0.60, 95% CI 0.37–0.98; p = 0.0402), severe complications (RR 0.41, 95% CI 0.24–0.70; p = 0.0011, respectively), and a shorter hospital stay (MD − 3.70 days, 95% CI − 4.80 to − 2.61; p < 0.0001). In patients with HCC, RLR is associated with superior prognosis and perioperative outcomes compared with LLR and RLR exhibits better perioperative outcomes than OLR.

1 June 2020 in Hepatobiliary & Pancreatic Diseases International
Verified
Journal Article
Closed access
YZYu Zhu
Yu Zhu
ZLZhen-Yu Li
Zhen-Yu Li
CWChun-Guo Wang
Chun-Guo Wang
ZFZhe-Ping Fang
Zhe-Ping Fang
WJWei-Dong Jia
Wei-Dong Jia
FZFabiao Zhang
Fabiao Zhang

1 March 2025 in Journal of Hepatocellular Carcinoma
Verified
Journal Article
Open access
PDF file
GZGuoqun Zheng
Guoqun Zheng
MZMinjie Zheng
Minjie Zheng
PHPeng Hu
Peng Hu
YZYu Zhu
Yu Zhu
WZWenlong Zhang
Wenlong Zhang
FZFabiao Zhang
Fabiao Zhang
Background: Hepatocellular carcinoma (HCC) is a common malignancy with a high recurrence rate following curative resection. This study aimed to identify factors contributing to early recurrence (within 2 years) and develop a Lasso-based nomogram for individualized risk assessment. Methods: We conducted a retrospective analysis of 206 hCC patients who underwent curative resection at Taizhou Hospital, Zhejiang Province, from January 2019 to August 2022. Patients were randomly divided into training (n=144) and validation (n=62) cohorts. Lasso regression was used to identify potential recurrence risk factors among 17 candidate predictors. A Cox proportional hazards model was constructed based on variables selected by Lasso. Model performance was assessed using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA). Results: Five independent predictors of early HCC recurrence were identified: age, serum alanine aminotransferase (ALT) levels, cirrhosis, tumor diameter, and microvascular invasion (MVI). The nomogram demonstrated area under the curve (AUC) values for recurrence-free survival (RFS) of 0.828 (95% confidence interval [CI]: 0.753– 0.904) at 1 year, 0.799 (95% CI: 0.718– 0.880) at 2 years, and 0.742 (95% CI: 0.642– 0.842) at 5 years in the training cohort. The corresponding AUCs in the validation cohort were 0.823 (95% CI: 0.686– 0.960), 0.804 (95% CI: 0.686– 0.922), and 0.857 (95% CI: 0.722– 0.992) at 1, 2 and 5 years, respectively. Calibration curves and DCA confirmed the nomogram’s high accuracy and clinical utility. Conclusion: The Lasso-Cox regression nomogram effectively predicts HCC recurrence within two years post-hepatectomy, providing a valuable tool for personalized postoperative management to improve patient outcomes.

2 September 2024 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
YZYu Zhu
Yu Zhu
AWAi-Dong Wang
Ai-Dong Wang
LGLing-Ling Gu
Ling-Ling Gu
QDQi-Qiang Dai
Qi-Qiang Dai
GZGuo-Qun Zheng
Guo-Qun Zheng
FZFabiao Zhang
Fabiao Zhang
Background: To identify the risk factors and construct a predictive model for early recurrence of hepatitis B virus(HBV-)- related hepatocellular carcinomas(HCCs) after radical resection.Data and methods: A total of 465 HBV-related HCC patients underwent radical resections between January 1, 2012 and August 31, 2018.Their data were collected through the inpatient information management system of the First Affiliated Hospital of University of Science and Technology of China. Survival and subgroup analyses of early recurrence among male and female patients were performed using Kaplan-Meier curves. The independent risk factors associated with early postoperative tumor recurrence were analyzed using multivariate Cox proportional hazards regression model. Based on these independent risk factors, a risk function model for early recurrence was fitted, and a column chart for the prediction model was drawn for internal and external validation.Results: A total of 181 patients developed early recurrences, including 156 males and 25 females. There was no difference in the early recurrence rates between males and females. Tumor diameters>5cm, microvascular invasion and albumin level5 cm, microvascular invasion, and albumin level<35 g/L were independent risk factors for early recurrence. The prediction model based on three clinical indicators could predict early recurrence, with good discrimination, calibration, and extrapolation.